BridgeMD
New treatment option for Depression, Anxiety
Official title SUpport From PEeRs to Expand Access Study - Community
ClinicalTrials.gov ID: NCT07186816
What this study is testing
- What it's testing
- Investigators will evaluate the implementation of an evidence-based, Spanish-language, digital, cognitive-behavioral therapy (dCBT) intervention (SilverCloud) in the Mission community for Latino patients with depression and/or anxiety. 213 participants will be enrolled in a one-armed trial comparing self-guided vs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- PHQ-9 ≥ 10 or GAD-7 ≥ 8
- Has access to the Internet via smartphone and/or broadband at home, and basic level of technological literacy or willingness to undergo a brief...
- ≥18 years of age
- Preference for receiving medical care in Spanish
- Not in concurrent psychotherapy
You likely can't join if
- Currently receiving psychotherapy, as this treatment will be offered as a frontline treatment for depression and anxiety, however, patients are...
- Visual, hearing, voice, or motor impairment or illiteracy that would prevent completion of study procedures
- Diagnosis of a psychotic disorder, bipolar disorder, dissociative disorder, or substance use disorder
- Severe suicidality (as assessed by expressing suicidal ideation, plan, and intent). Although procedures with back-up plans are in place for patients...
See the full eligibility criteria
- PHQ-9 ≥ 10 or GAD-7 ≥ 8
- Has access to the Internet via smartphone and/or broadband at home, and basic level of technological literacy or willingness to undergo a brief technology use training
- ≥18 years of age
- Preference for receiving medical care in Spanish
- Not in concurrent psychotherapy
- If currently taking an antidepressant medication, patient must have been on a stable dose for at least 6 weeks, and have no plans to change the dose. We will permit patients on antidepressants to enter the study, as...
- Currently receiving psychotherapy, as this treatment will be offered as a frontline treatment for depression and anxiety, however, patients are allowed to be referred to treatment while participating in this study and...
- Visual, hearing, voice, or motor impairment or illiteracy that would prevent completion of study procedures
- Diagnosis of a psychotic disorder, bipolar disorder, dissociative disorder, or substance use disorder
- Severe suicidality (as assessed by expressing suicidal ideation, plan, and intent). Although procedures with back-up plans are in place for patients who develop suicidality (see Human people Section), patients assessed...
The study team makes the final eligibility decision.
Where it's taking place
- San Francisco, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Francisco, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.